Clinical Disorders of Leukocyte Functions

  • Harry R. Hill
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 14)


After being questioned by a colleague about my current endeavors with a large number of reprints, reference printouts, and writing pads apparent, I informed him that I was writing another review on clinical abnormalities of phagocyte function. Why write another such review, I was asked, as there are a number of these in the current literature (Gallin, 1981; Lohr and Snyderman, 1981; Hill, 1981a; Gallin et al., 1980; Hill, 1982; Charette and Hill, 1980; Mills and Quie, 1980; Johnston and Newman, 1977; Baehner, 1974; Stossel, 1974). That’s a very good question, which momentarily dimmed my enthusiasm for the project. I believe, however, that the study of phagocyte disorders has turned the corner from that of a purely descriptive, and somewhat inexact, science to one that is applying the rapidly developing tools of cell biology to look into the mechanisms of these fascinating disorders. Thus, cell surface receptors, membrane potential changes, ion fluxes, cyclic nucleotide alterations, protein phosphorylation, microtubule and microfilament function, as well as the various critical metabolic pathways, are being carefully dissected in polymorphonuclear keukocytes (PMNs), monocytes (Mns), and macrophages (Macs). The knowledge gained from these critically important cells in the host-defense mechanism is now spilling over into the study of other cell types, such as those in muscle, liver, bone, and nervous tissue, which are much more difficult to obtain and study. Thus, in many aspects of cell physiology, we—the phagocyte people—are at the forefront of knowledge and scientific investigation.


Chronic Granulomatous Disease Respiratory Burst Activity Microbicidal Activity Chronic Granulomatous Disease Patient Leukocyte Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abramson, J. S., Giebink, G. S., and Quie, P. G., 1982, Influenzae A virus induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media, Infect. Immun. 36:289.PubMedGoogle Scholar
  2. Afzelius, B. A., Ewetz, I., Palmblad, J., Uden, A. M., and Venizelos, N., 1980, Structure and function of neutrophil leukocytes from patients with the immotile-cilia syndrome, Acta Med. Scand. 208:145.PubMedGoogle Scholar
  3. Aggett, P. G., Harries, J. T., Harvey, B. A. M., and Soothill, J. F., 1979, An inherited defect of neutrophil mobility in Shwachmann syndrome, J. Pediatr. 94:391.PubMedGoogle Scholar
  4. Allen, R. C., and Loose, L. D., 1976, Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages, Biochem. Biophys. Res. Commun. 69:245.PubMedGoogle Scholar
  5. Allen, R. C., Yevich, S. J., Orth, R. W., and Steel, R. H., 1974, The superoxide anion and singlet molecular oxygen: Their role in the microbicidal activity of the polymorphonuclear leukocyte, Biochem. Biophys. Res. Commun. 60:909.PubMedGoogle Scholar
  6. Allred, C. D., Shigeoka, A. O., and Hill, H. R., 1979, Evaluation of Group B streptococcal opsonins by radiolabeled bacterial uptake, J. Immun. Methods 25:355.Google Scholar
  7. Allred, C. D., Margetts, J., and Hill, H. R., 1980, Luminol induced neutrophil chemiluminescence, Biochem. Biophys. Acta 631:380.PubMedGoogle Scholar
  8. Alper, C. A., Cotton, H. R., Rosen, F. S., Rabson, A. R., MacNab, G. M., and Gear, J. S. S., 1972, Homozygous deficiency of C3 in a patient with repeated infections, Lancet 2:1179.PubMedGoogle Scholar
  9. Alper, C. A., Colten, H. R., Gear, J. S. S., Rabson, A. R., and Rosen, F. S., 1976, Homozygous human C3 deficiency, J. Clin. Invest. 57:222.PubMedGoogle Scholar
  10. Altman, L. C., Snyderman, R., and Blaese, R. M., 1974, Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome, J. Clin. Invest. 54:486.PubMedGoogle Scholar
  11. Altman, L. C., Furukawa, C. T., and Klebanoff, S. J., 1977a, Depressed mononuclear leukocyte chemotaxis in thermally injured patients, J. Immunol. 119:199.PubMedGoogle Scholar
  12. Altman, L. C., Furukawa, C. T., and Klebanoff, S. J., 1977 b, Defective polymorphonuclear leukocyte (PMN) function in thermally injured patients, Clin. Res. 25:117A. (Abstr.)Google Scholar
  13. Ament, M. E., and Ochs, H. D., 1973, Gastrointestinal manifestations of chronic granulomatous disease, N. Engl. J. Med. 288:382.PubMedGoogle Scholar
  14. Anderson, D. C., Hughes, B. J., and Smith, C. W., 1981, Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship of impaired redistribution of surface adhesion sites by chemotactic factor or colchicine, J. Clin. Invest. 68:863.PubMedGoogle Scholar
  15. Anderson, R., 1981, Assessment of oral ascorbate in three children with chronic granulomatous disease and defective neutrophil motility over a 2 year period, Clin. Exp. Immunol. 43:180.PubMedGoogle Scholar
  16. Anderson, R., and Dittrich, O. C., 1979, Effects of ascorbate on leucocytes. Part IV. Increased neutrophil function and clinical improvement after oral ascorbate in two patients with chronic granulomatous disease, South Afr. Med. J. 56:476.Google Scholar
  17. Anderson, R., Glover, A., Koornhof, H. J., and Rabson, A. R., 1976a, In vitro stimulation of neutrophil motility by levamisole: Maintenance of cGMP levels in chemotactically stimulated levamisole-treated neutrophils, J. Immunol. 117:428.PubMedGoogle Scholar
  18. Anderson, R., Rabson, A. R., Sher, R., and Koornhof, H. J., 1976b, Defective neutrophil motility in children with measles, J. Pediatr. 8,9:27.Google Scholar
  19. Anderson, R., Glover, A., and Rabson, A. R., 1977, The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels, J. Immunol. 118:1690.PubMedGoogle Scholar
  20. Anderson, R., Hay, I., Van Wyk, H., Oosthuizen, R., and Theron, A., 1980, The effect of ascorbate on cellular humoral immunity in asthmatic children, South Afr. Med. J. 58: 974.Google Scholar
  21. Arnaout, M. A., Pitt, J., Cohen, H. J., Melamed, J., Rosen, F. S., and Colten, H. R., 1982, Deficiency of a granulocyte-membrane glycoprotein in a boy with recurrent bacterial infections, N. Engl. J. Med. 306:693.PubMedGoogle Scholar
  22. Baehner, R. L., 1974, Molecular basis for functional disorders of phagocytes, J. Pediatr. 84: 317.PubMedGoogle Scholar
  23. Baehner, R. L., and Nathan, D. G., 1968, Quantitative nitroblue tetrazolium test in chronic granulomatous disease, N. Engl. J. Med. 278:971.PubMedGoogle Scholar
  24. Bale, J. F., Jr., Wilson, J. F., and Hill, H. R., 1977, Fatal histiocytic lymphoma of the brain associated with hyperimmunoglobulinemia E and recurrent infections, Cancer 39:2386.PubMedGoogle Scholar
  25. Balfour, H. H., Shehan, J. J., Speicher, C. C., and Kauder, E., 1971, Chronic granulomatous disease of childhood in a 23 year old man, JAMA 7:960.Google Scholar
  26. Ballow, M., Shira, J. E., Harden, L., Yang, S. Y., and Day, N. K., 1975, Complete absence of the third component of complement in man, J. Clin. Invest. 56:703.PubMedGoogle Scholar
  27. Bannatyne, R. M., Skawrom, P. N., and Weber, J. L., 1969, Job’s syndrome: A variant of chronic granulomatous disease, J. Pediatr. 75:236.PubMedGoogle Scholar
  28. Bass, D. A., DeChatelet, L. R., Burk, R. F., Shirley, P., and Szejda, P., 1977, Polymorphonuclear leukocyte bactericidal activity and oxidative metabolism during glutathione peroxidase deficiency, Infect. Immun. 18:78.PubMedGoogle Scholar
  29. Bassaris, H. P., Lianou, P. E., Shoutelis, A. T., Papavassiliou, J. T., and Phair, J. P., 1982, Defective adherence of polymorphonuclear leukocytes to nylon induced by thalassemic serum, J. Infect. Dis. 146:52.PubMedGoogle Scholar
  30. Baum, J., Mowat, A. G., and Kirk, J. A., 1971, A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood, J. Lab. Clin. Med. 77: 501.PubMedGoogle Scholar
  31. Beeuwkes, H., and Bulsma, A., 1974, Reduced chemotaxis of polymorphonuclear leukocytes in sera from patients with rheumatoid arthritis, Antonie van Leeuwenhock 40:233.Google Scholar
  32. Berendes, H., Bridges, R. H., and Good, R. A., 1957, A fatal granulomatous disease of childhood: The clinical study of a new syndrome, Minn. Med. 40:309.PubMedGoogle Scholar
  33. Berger, M., Kirkpatrick, C. H., Goldsmith, P. K., and Gallin, J. I., 1980, IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulinemia E and recurrent infections, J. Immunol. 115:2437.Google Scholar
  34. Björksten, B., and Lundmark, K. M., 1976, Recurrent bacterial infections in four siblings with neutropenia, eosinophilia, hyperimmunoglobulinemia A, and defective neutrophil chemotaxis, J. Infect. Dis. 133:63.PubMedGoogle Scholar
  35. Blum, R., Geller, G., and Fish, L. A., 1977, Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic responses in two generations, J. Pediatr. 90:607.PubMedGoogle Scholar
  36. Blume, R. S., and Wolff, S. M., 1972, The Chediak-Higashi syndrome: Studies in four patients and a review of the literature, Medicine (Baltimore) 51:247.Google Scholar
  37. Borregaard, N., Johansen, K. S., and Esmann, V., 1979, Quantitation of superoxide production in human polymorphonuclear leukocytes from normals and 3 types of chronic granulomatous disease, Biochem. Biophys. Res. Commun. 90:214.PubMedGoogle Scholar
  38. Borregaard, N., Kragballe, K., Brandrup, F., Koch, C., and Johansen, E. S., 1981, Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease, Clin. Exp. Immunol. 43:390.PubMedGoogle Scholar
  39. Bowen, T. J., Ochs, H. D., Altman, L. C., Klebanoff, S. J., Page, R. C., Perkins, W. D., Carter, W. B., Wedgwood, R. J., and Price, T. H., 1980, A cellular chemotactic and adherence defect associated with recurrent bacterial infections, abnormal umbilical cord separation, and severe periodontitis, Pediatr. Res. 14:544.Google Scholar
  40. Boxer, L. A., Hedley-Whyte, E. J., and Stossel, J. P., 1974, Neutrophil actin dysfunction and abnormal neutrophil behavior, N. Engl. J. Med. 291:1093.PubMedGoogle Scholar
  41. Boxer, L. A., Wantanbe, A. M., Rister, M., Besch, H. R., Jr., Allen, J., and Baehmer, R. L., 1976, Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate, N. Engl. J. Med. 295:1041.PubMedGoogle Scholar
  42. Boxer, L. A., Oliver, J. M., Spielberg, S. P., Allen, J. M., and Schulman, J. D., 1979, Protection of granulocytes by vitamin E in gluthathione synthetase deficiency, N. Engl. J. Med. 301:901.PubMedGoogle Scholar
  43. Boyden, S., 1962, The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes, J. Exp. Med. 115:453.PubMedGoogle Scholar
  44. Brayton, R. G., Stokes, P. E., Schwartz, M. S., and Louria, O. B., 1970, Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing, N. Engl. J. Med. 282:123.PubMedGoogle Scholar
  45. Breton-Gorius, J., Mason, D. Y., Buriot, D., Vilde, J. L., and Griscelli, C., 1980, Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections, Am. J. Pathol. 99:413.PubMedGoogle Scholar
  46. Bridges, R. A., Berendes, H., and Good, R. A., 1959, A fatal granulomatous disease of childhood. The clinical, pathological, and laboratory features of a new syndrome, Am. J. Dis. Child. 97:387.Google Scholar
  47. Briggs, R. T., Karnovsky, M. L., and Karnovsky, M. J., 1977, Hydrogen peroxide production in chronic granulomatous disease, J. Clin. Invest. 59:1088.PubMedGoogle Scholar
  48. Bryant, S. M., Lynch, R. E., and Hill, H. R., 1982, Kinetic analysis of superoxide anion production by activated and resident murine peritoneal macrophages, Cell Immunol. 69:46.PubMedGoogle Scholar
  49. Buckley, R. H., Wray, B. B., and Belmaker, E. Z., 1972, Extreme hyperimmunoglobulinemia E and undue susceptibility to infection, Pediatrics 49:59.PubMedGoogle Scholar
  50. Businco, L., Laurenti, R., Rossi, P., Galli, E., and Aiuti, F., 1981, A child with atopic features, raised serum IgE and recurrent infection treated with levamisole, Arch. Dis. Child. 56:60.PubMedGoogle Scholar
  51. Caleb, M., Lecks, H., South, M. A., and Norman, M. E., 1977, Kartageners syndrome and abnormal cilia. (Letter.), N. Engl. J. Med. 297:1012.Google Scholar
  52. Charette, R. P., and Hill, H. R., 1982, Defects in phagocytic cells, in: Infections in Children (R. J. Wedgewood, S. D. Davis, C. G. Ray, and V. C. Kelly, eds.), pp. 109–125, Harper and Row, Philadelphia.Google Scholar
  53. Cheson, B. D., Christensen, R. L., Sperling, R., Kohler, B. E., and Babior, B. M., 1976, The origin of the chemiluminescence of phagocytosing granulocytes, J. Clin. Invest. 58:789.PubMedGoogle Scholar
  54. Christensen, R. D., Rothstein, G., Bradley, P., Priebat, D., Bybee, B., and Anstall, H. B., 1982, Granulocyte transfusions in neonates with bacterial sepsis, neutropenia and depletion of marrow neutrophils, Pediatrics 70:1.PubMedGoogle Scholar
  55. Chusid, M. J., Gallin, J. I., Dale, D. C., Fauci, A. S., and Wolff, S. M., 1976, Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections, Pediatrics 58:513.PubMedGoogle Scholar
  56. Cianciola, L. J., Genco, R. J., Patters, M. T., McKenna, J., and Van Oss, C. J., 1977, Defective polymorphonuclear leukocyte function in human periodontal disease, Nature 265: 445.Google Scholar
  57. Clark, R. A., and Kimball, H. R., 1971, Defective granulocyte chemotaxis in the ChediakHigashi syndrome, J. Clin. Invest. 50:2645.PubMedGoogle Scholar
  58. Clark, R. A., and Klebanoff, S. J., 1978, Chronic granulomatous disease: Studies of a family with impaired neutrophil chemotactic, metabolic and bactericidal function, Am. J. Med. 65:941.PubMedGoogle Scholar
  59. Clark, R. A., Root, R. K., Kimball, H. R., and Kirkpatrick, C. H., 1973, Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infection, Ann. Intern. Med. 78:515.PubMedGoogle Scholar
  60. Clark, R. A., Page, R. C., and Wilde, G., 1977, Defective neutrophil chemotaxis in juvenile periodontitis, Infect. Immun. 18:694.PubMedGoogle Scholar
  61. Cohen, M. S., Isturiz, R. E., Malech, H. L., Root, R. K., Wilfert, C. M., Gutman L., and Buckley, R. H., 1981, Fungal infection in chronic granulomatous disease, Am. J. Med. 71:59.PubMedGoogle Scholar
  62. Corberand, J., DeLarrard, B., Vergnes, H., and Carriere, J.-P., 1978, Chronic granulomatous disease with leukocytic glucose-6-phosphate dehydrogenase deficiency in a 28-monthold girl, Amer. J. Clin. Path. 70:296.Google Scholar
  63. Craddock, P. R., Yawata, Y., VanSanten, L., Gilberstadt, S., Silvis, S., and Jacobs, H. S., 1974, Acquired phagocyte dysfunction: A complication of the hypophosphatemia of parenteral hyperalimentation, N. Engl. J. Med. 290:1403.PubMedGoogle Scholar
  64. Craddock, P. R., Fehr, J., Brigham, K. L., Kronenberg, R. S., and Jacob, H. S., 1977a, Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis, N. Engl. J. Med. 196:770.Google Scholar
  65. Craddock, P. R., Fehr, J., Dalmasso, A. P., Brigham, K. L., and Jacob, H. S., 1977 b, Hemodialysis leukopenia—Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes, J. Clin. Invest. 59:879.PubMedGoogle Scholar
  66. Craddock, P. R., White, J. G., and Jacob, H. S., 1978, Potentiation of complement (C5a)induced granulocyte aggregation by cytochalasin B, J. Lab. Clin. Med. 91:490.PubMedGoogle Scholar
  67. Craddock, P. R., Hammerschmidt, D. E., Moldow, C. F., Yamada, O., and Jacob, H. S., 1979, Granulocyte aggregation as a manifestation of membrane interactions with complement: Possible role in leukocyte margination, microvascular occlusion and endothelial damage, Semin. Hematol. 16:140.PubMedGoogle Scholar
  68. Crowley, C. A., Curnutte, J. T., Rosin, R. E., Andre-Schwartz, J., Gallin, J. I., Klempner, M., Snyderman, R., Southwick, F. S., Stossel, T. P., and Babior, B. M., 1980, An inherited abnormality of neutrophil adhesion, N. Engl. J. Med. 302:1163.PubMedGoogle Scholar
  69. Curnutte, J. T., Kipnes, R. S., and Babior, B. M., 1975, Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease, N. Engl. J. Med. 293:628.PubMedGoogle Scholar
  70. Cutler, J. E., 1974, A simple in vitro method for studies on chemotaxis, Proc. Soc. Exp. Biol. Med. 147:471.PubMedGoogle Scholar
  71. Dahl, M. V., Greene, W. H., and Quie, P. G., 1976, Infection, dermatitis, increased IgE and impaired neutrophil chemotaxis, Arch. Dermatol. 112:1387.PubMedGoogle Scholar
  72. Dale, D. C., Fauci, A. S., and Wolff, S. M., 1974, Alternate day prednisone—Leukocyte kinetics and susceptibility to infections, N. Engl. J. Med. 291:1154.PubMedGoogle Scholar
  73. Davis, A. T., Brunning, R. D., and Quie, P. G., 1971, Polymorphonuclear leukocyte myeloperoxidase deficiency in a patient with myelomonocytic leukemia, N. Eng. J. Med. 285:789.Google Scholar
  74. Davis, J. M., Dineen, P., and Gallin, J. I., 1980, Neutrophil degranulation and abnormal chemotaxis after thermal injury, J. Immunol. 124:1467.PubMedGoogle Scholar
  75. Davis, S. D., Schaller, J., and Wedgwood, R. J., 1966, Job’s syndrome: Recurrent “cold” staphylococcal abscesses, Lancet 1:1013.PubMedGoogle Scholar
  76. Davis, W. C., Douglas, S. D., and Fudenberg, H. H., 1968, A selective neutrophil dysfunction syndrome: Impaired killing of staphyloccocci, Ann. Intern. Med. 69:1237.PubMedGoogle Scholar
  77. Densen, P., Wilkinson-Kroovand, S., Mandell, G. L., Oyen, R., and Marsh, W. L., 1981, Kx: Its relationship to chronic granulomatous disease and genetic linkage with Xg, Blood 58:34.PubMedGoogle Scholar
  78. Desnick, R. J., Sharp, H. L., Grabowski, G. A., Brunning, R. D., Quie, P. G., Sung, J. H., Gorlin, R. J., and Ikonne, J. V., 1976, Mannosidosis: Clinical, morphologic, immunologic and biochemical studies, Pediatr. Res. 10:985.PubMedGoogle Scholar
  79. Donabedian, H., Ailing, D. W., and Gallin, J. I., 1982, Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent infection (Job’s) syndrome, N. Engl. J. Med. 307:290.PubMedGoogle Scholar
  80. English, D., and McPherson, T. A., 1977, Chemotaxis radioassays: A simplified, quantitative method using technetium 99m radiocolloid labeled granulocytes, Am. J. Hematol. 3:245.PubMedGoogle Scholar
  81. Ezer, G., and Soothill, J. F., 1974, Intracellular bactericidal effects of rifampicin in both normal and chronic granulomatous disease polymorphs, Arch. Dis. Child. 49:463.PubMedGoogle Scholar
  82. Fischer, T. J., Gard, S. E., Rachelefsky, G. S., Klein, R. B., Borut, T. C., and Stiehm, R. E., 1980, Monocyte chemotaxis under agarose: Defects in atopic disease, aspirin therapy, and mucocutaneous candidiasis, Pediatr. Res. 14:242.PubMedGoogle Scholar
  83. Ford, D. K., Price, G. E., Culling, C. F. A., and Vassar, P. S., 1962, Familial lipochrome pigmentation of histiocytes with hyperglobulinemia, pulmonary infiltration, splenomegaly, arthritis and susceptibility to infection, Am. J. Med. 33:478.PubMedGoogle Scholar
  84. Friedlander, A. M., 1978, DNA release as a direct measure of microbial killing by phagocytes, Infect. Immun. 22:148.PubMedGoogle Scholar
  85. Gallin, J. I., 1981, Abnormal phagocyte chemotaxis: Pathophysiology, clinical manifestations, and management of patients, Rev. Infect. Dis. 3:1196.PubMedGoogle Scholar
  86. Gallin, J. I., Clark, R. A., and Kimball, H. R., 1973, Granulocyte chemotaxis: An improved in vitro assay employing 51 Cr-labeled granulocytes, J. Immunol. 110:233.PubMedGoogle Scholar
  87. Gallin, J. I., Gallin, E. K., Malech, H. L., and Cramer, E. B., 1978, Structural and ionic events during leukocyte chemotaxis, in: Leukocyte Chemotaxis (J. I. Gallin and P. G. Quie eds.), pp. 123–140, Raven Press, New York.Google Scholar
  88. Gallin, J. I., Elin, R. J., Hubert, R. T., Fauci, A. S., Kaliner, M. A., and Wolff, S. M., 1979, Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): Studies in humans and mice, Blood 53:226.PubMedGoogle Scholar
  89. Gallin, J. I., Wright, D. G., Malech, H. L., Davis, J. M., Klepner, M. S., and Kirkpatrick, C. H., 1980, Disorders of phagocyte chemotaxis, Ann. Intern. Med. 92:520.PubMedGoogle Scholar
  90. Genco, R. J., Van Dyke, T. E., Park, B., Ciminelli, M., and Horoszewicz, H., 1980, Neutrophil chemotaxis impairment in juvenile periodontitis: Evaluation of specificity, adherence, deformability, and serum factors, J. Reticuloendothelial Soc. 28:815.Google Scholar
  91. Giebink, G. S., Mills, E. L., Huff, J. S., Cates, K. L., Juhn, S. K., and Quie, P. G., 1979, Polymorphonuclear leukocyte dysfunction in children with recurrent otitis media, Pediatrics 94:13.Google Scholar
  92. Gmünder, F. K., and Seger, R. A., 1981, Chronic granulomatous disease: Mode of action of sulfamethoxazole/trimethoprim, Pediatr. Res. 15:1533.Google Scholar
  93. Gold, S. B., Hanes, D. M., Stites, D. P., and Fudenberg, H. H., 1974, Abnormal kinetics of degranulation in chronic granulomatous disease, N. Engl. J. Med. 291:332.PubMedGoogle Scholar
  94. Gray, G. R., and Klebanoff, S. J., Stamatoyannopoulos, G., Naiman, S. C., Kliman, M. R., Klebanoff, S. J., Austin, T., Yoshida, A., and Robinson, G. C. F., 1973, Neutrophil dysfunction, chronic granulomatous disease and non-spherocytic haemolytic anemia caused by complete deficiency of glucose-6-phosphate dehydrogenase, Lancet 2:530.PubMedGoogle Scholar
  95. Gregory, L., Williams, R., and Thompson, E., 1972, Leukocyte function in Down’s syndrome and acute leukemia, Lancet 1:1359.PubMedGoogle Scholar
  96. Griscom, N. T., Kirkpatrick, J. A., Girdany, B. R., Berdon, W. E., Grand, R. J., and Mackie, G. G., 1974, Gastric antral narrowing in chronic granulomatous disease of childhood, Pediatrics 54:456.PubMedGoogle Scholar
  97. Hammerschmidt, D. E., Bowers, T. K., Lammi-Keffe, C. J., Jacob, H. S., and Craddock, P. R., 1980, Granulocyte aggregometry: A sensitive technique for the detection of C5a and complement activation, Blood 55:898.PubMedGoogle Scholar
  98. Hammerschmidt, D. E., Weaver, L. J., Hudson, L. D., Craddock, P. R., and Jacob, H. S., 1980, Association of complement activation and elevated plasma-05a with adult respiratory distress syndrome, Lancet 1:947.PubMedGoogle Scholar
  99. Harvath, L., and Andersen, B. R., 1979, Defective initiation of oxidative metabolism in polymorphonuclear leukocytes, N. Engl. J. Med. 300:1130.PubMedGoogle Scholar
  100. Hayward, A. R., Leonard, J., Wood, C. B. S., Harvey, B. A. M., Greenwood, M. D., and Soothill, J. F., 1979, Delayed separation of the umbilical cord, widespread infections and defective neutrophil mobility, Lancet 1:1099.PubMedGoogle Scholar
  101. Helium, K. B., and Solberg, C. O., 1977, Human leukocyte migration: Studies with an improved skin chamber technique, Acta Pathol. Microbiol. Scand. [C] 85:413.Google Scholar
  102. Hemming, V. G., Hall, R. T., Rhoades, P. G., Shigeoka, A. O., and Hill, H. R., 1976, Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence, J. ain. Invest. 48:1379.Google Scholar
  103. Henderson, L. W., Miller, M. E., Hamilton, R. W., and Norman, M. E., 1975, Hemodialysis leukopenia and polymorph random mobility-a possible correlation, J. Lab. Clin. Med. 85:191.PubMedGoogle Scholar
  104. Hill, H. R., 1979a, Biochemical control of phagocyte function, in Pediatric Immunology (H. Hodes and B. M. Kogan, eds.), pp. 15–28, Science and Medicine, New York.Google Scholar
  105. Hill, H. R., 1979b, Immunity in the diabetic: Impaired or enhanced? (Editorial.) West. J. Med. 130:547.PubMedGoogle Scholar
  106. Hill, H. R., 1980, Laboratory aspects of immune deficiency in children, Pediatr. Clin. North Am. 27:805.PubMedGoogle Scholar
  107. Hill, H. R., 1981a, Granulocyte disorders predisposing to infection, in: Pediatric Update (E. R. Stiehm and A. J. Moss, eds.), 3rd ed., pp. 321–337, Elsevier, New York.Google Scholar
  108. Hill, H. R., 1981b, Phagocyte transfusion: Ultimate therapy of neonatal infection, J. Pediatr. 98:59.PubMedGoogle Scholar
  109. Hill, H. R., 1982, The syndrome of hyperimmunoglobulinemia E and recurrent infections, Am. J. Dis. Child. 136:767.PubMedGoogle Scholar
  110. Hill, H. R., and Patriarca, P, 1982, Clinical application of leukocyte function tests, in Biochemistry and Function of Phagocytes (F. Rossi and P. Patriarca, eds.), pp. 659–682, Advances in Experimental Biology., Vol. 141, Plenum Press, New York.Google Scholar
  111. Hill, H. R., and Quie, P. G., 1974a, Contradiction in neutrophil chemotaxis in bacterial infection, J. Pediatr. 85:444.Google Scholar
  112. Hill, H. R., and Quie, P. G., 1974b, Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections, Lancet 1:183.PubMedGoogle Scholar
  113. Hill, H. R., Gerrard, J. M., Hogan, N. A. and Quie, P. G., 1974a, Hyperactivity of neutrophil leukotactic responses during active bacterial infection, J. Clin. Invest. 53:996.PubMedGoogle Scholar
  114. Hill, H. R., Kaplan, E. L., Dajani, A., Wannamaker, L. W. and Quie, P. G., 1974b, Leukotactic activity and reduction of nitroblue tetrazolium by neutrophil granulocytes from patients with streptococcal skin infections, J. Infect. Dis. 129:322.PubMedGoogle Scholar
  115. Hill, H. R., Sauls, H. S., Dettloff, J. L., and Quie, P. G., 1974c, Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus, Clin. Immunol. Immunopathol. 2:395.PubMedGoogle Scholar
  116. Hill, H. R., Quie, P. G., Pabst, H. F., Ochs, H. D., Clark, R. A., Klebanoff, S. J., and Wedgwood, R. J., 1974d, Defect in neutrophil granulocyte chemotaxis in Job’s syndrome of recurrent “cold” staphylococcal abscesses, Lancet 2:617.Google Scholar
  117. Hill, H. R., Warwick, W. J., Dettloff, J., and Quie, P. G., 1974e, Neutrophil granulocyte function in patients with pulmonary infections, J. Pediatr. 84:55.PubMedGoogle Scholar
  118. Hill, H. R., Hogan, N. A., Mitchell, T. G., and Quie, P. G., 1975, Evaluation of a cytocentrifuge method for measuring neutrophil granulocyte chemotaxis, J. Lab. Clin. Med. 86:703.PubMedGoogle Scholar
  119. Hill, H. R., Estensen, R. D., Hogan, N. A., and Quie, P. G., 1976a, Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis, J. Lab. Clin. Med. 88:796.PubMedGoogle Scholar
  120. Hill, H. R., Williams, P. B., Krueger, G. G., and Janis, B., 1976b, Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis, Ann. Intern. Med. 85:39.PubMedGoogle Scholar
  121. Hill, H. R., Book, L. S., Hemming, V. G., and Herbst, J. J., 1977, Defective neutrophil chemotactic responses in patients with recurrent episodes of otitis media and chronic diarrhea, Am. J. Dis. Child. 131:433.PubMedGoogle Scholar
  122. Hill, H. R., Augustine, N. H., Rallison, M. L., and Santos, J. I., 1983, Defective monocyte chemotactic responses in diabetes mellitus, J. Clin. Immunol. 3:70.PubMedGoogle Scholar
  123. Hogan, N. A., and Hill, H. R., 1978, Levamisole enhances PMN chemotaxis and elevates cellular cyclic GMP, J. Infect. Dis. 138:437.PubMedGoogle Scholar
  124. Hohn, D. C., and Lehrer, R. I., 1975, NADPH oxidase deficiency in X-linked chronic granulomatous disease, J. Clin. Invest. 55:707.PubMedGoogle Scholar
  125. Holmes, B., Page, A. R., and Good, R. A., 1967, Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocyte function, J. Clin. Invest. 46:1422.PubMedGoogle Scholar
  126. Holmes, B., Park, B. H., Malawista, S. E., Quie, P. G., Nelson, D. L., and Good, R. A., 1970, Chronic granulomatous disease in females: A deficiency of leukocyte glutathione peroxidase, N. Engl. J. Med. 283:217.PubMedGoogle Scholar
  127. Hosea, S., Brown, E., Hammer, C., and Frank, M., 1980, Role of complement activation in a model of adult respiratory distress syndrome, J. Clin. Invest. 66:375.PubMedGoogle Scholar
  128. Ingraham, L. M., Boxer, L. A., Haak, R. A., and Baehner, R. L., 1981, Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes, Blood 58:830.PubMedGoogle Scholar
  129. Issekutz, A. C., Lee, K. Y., and Bigger, W. D., 1978, Neutrophil chemotaxis in two patients with recurrent staphylococcal skin infections and hyperimmunoglobulinemia E, J. Lab. Clin. Med. 92:640.PubMedGoogle Scholar
  130. Jacob, H. S., Craddock, P. R., Hammerschmidt, D. E., and Moldow, C. F., 1980, Complement-induced granulocyte aggregation, N. Engl. J. Med. 302:789.PubMedGoogle Scholar
  131. Jacobs, J. C., and Norman, M. E., 1977, A familial defect of neutrophil chemotaxis with asthma, eczema, and recurrent skin infections, Pediatr. Res. 11:732.PubMedGoogle Scholar
  132. Janeway, C. A., Craig, J., Davidson, M., Downey, W., Gitlin, D., and Sullivan, J. C., 1954, Hypergammaglobulinemia associated with severe recurrent and chronic nonspecific infection, Am. J. Dis. Child. 88:388.Google Scholar
  133. Johansen, K. S., Borregaard, N., Koch, C., Taudort, E., Wandall, J. H., and Repine, J. E., 1982, Chronic granulomatous disease presenting as xanthogranulomatous pyelonephritis in late childhood, J. Pediatr. 100:98.PubMedGoogle Scholar
  134. Johnston, R. B., and Newman, S. L., 1977, Chronic granulomatous disease, Pediatr. Clin. North Am. 24:365.PubMedGoogle Scholar
  135. Johnston, R. B., Jr., Klemperer, M. R., Alper, C. A., and Rosen, F. S., 1969, The enhancement of bacterial phagocytosis by serum: The role of complement components and two cofactors, J. Exp. Med. 129:1275.PubMedGoogle Scholar
  136. Johnston, R. B., Wilfert, C. M., Buckley, R. H., Webb, L. S., De Chatelet, L. R. and McCall, C. E., 1975, Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphisoxazole, Lancet 1:824.PubMedGoogle Scholar
  137. Keller, H. U., Wilkinson, P. C., Abercrombie, M., Becker, E. L., Hirsch, J. G., Miller, M. E., Ramsey, W. S., and Zigmond, S. H., 1977, A proposal for the definition of terms related to locomotion of leukocytes and other cells, Clin. Exp. Immunol. 27:377.PubMedGoogle Scholar
  138. Kimura, G. M., Miller, M. E., Leake, R. D., Raghunathan, R., and Cheung, A. T. W., 1981, Reduced concanavalin A capping of neonatal polymorphonuclear leukocytes (PMNs), Pediatr. Res. 15:1271.PubMedGoogle Scholar
  139. Kitahara, M., Eyre, H. J., and Hill, H. R., 1980, Monocyte functional and metabolic activity in malignant and inflammatory diseases, J. Lab. Clin. Med. 93:472.Google Scholar
  140. Klein, R. B., Fischer, T. J., Gard, S. E., Biberstein, M., Rich, K. C., and Stiehm, E. R., 1977, Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children, Pediatrics 60:467.PubMedGoogle Scholar
  141. Klempner, M. S., and Styrt, B., 1981, Clindamycin uptake by human neutrophils, J. Infect. Dis. 144:472.PubMedGoogle Scholar
  142. Klempner, M. S., Gallin, J. I., Balow, J. E., and VanKammen, D. P., 1980, The effect of hemodialysis and C5a des arg on neutrophil subpopulations. Blood 55:777.PubMedGoogle Scholar
  143. Komiyana, A., Morosawa, H., Nakahata, T., Miyagawa, Y., and Akabane, T., 1979, Abnormal neutrophil maturation in a neutrophic defect with morphologic abnormality and impaired function, J. Pediatr. 94:19.Google Scholar
  144. Kramer, N., Perez, H. D., and Goldstein, I. M., 1980, An immunoglobulin (IgG) inhibitor of polymorphonuclear leukocyte motility in a patient with recurrent infection, N. Engl. J. Med. 303:1253.PubMedGoogle Scholar
  145. Lavine, W. S., Maderazo, E. G., Stolman, J., Ward, P. A., Cogen, R. B., Greenblatt, I., and Robertson, P. B., 1979, Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis, J. Periodont. Res. 14:10.PubMedGoogle Scholar
  146. Leber, T., 1888, Ueber die entstehung der entzündung und die wirkung der entzundungserregenden Schädlichkeiten, Fortschr. Med. 6:460.Google Scholar
  147. Lehrer, R. I., and Cline, M. J., 1969, Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection, J. Clin. Invest. 48:1478.PubMedGoogle Scholar
  148. Lentnek, A. L., Schreiber, A. D., and MacGregor, R. R., 1976, Induction of augmented granulocyte adherence in inflammation; mediation by a plasma factor, J. Clin. Invest. 57:1098.PubMedGoogle Scholar
  149. Lew, P. D., Southwick, F. S., Stossel, T. P., Whitin, J. C., Simons, E., and Cohen, H. J., 1981, A variant of chronic granulomatous disease: Deficient oxidative metabolism due to a low-affinity NADPH oxidase, N. Engl. J. Med. 305:1329.PubMedGoogle Scholar
  150. Lohr, K. M., and Snyderman, R., 1981, Disorders of human leukocyte chemotaxis, Clin. Immunol. Rev. 1:67.PubMedGoogle Scholar
  151. MacDougall, L. G., Anderson, R., McNab, G. M., and Katz, J., 1975, The immune response in iron deficient children: Impaired cellular defense mechanisms with altered humoral components, J. Pediatr. 86:833.PubMedGoogle Scholar
  152. MacGregor, R. R., 1977, Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine and glucocorticoids, Ann. Intern. Med. 86:35.Google Scholar
  153. MacGregor, R. R., Spagnuolo, P. J., and Lentnek, A. L., 1974, Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system, N. Engl. J. Med. 291:642.PubMedGoogle Scholar
  154. MacGregor, R. R., Macarak, E. J., and Kefalides, N. A., 1978, Comparative adherence of granulocytes to endothelial monolayers and nylon fiber, J. Clin. Invest. 61:697.PubMedGoogle Scholar
  155. Maderazo, E. G., Ward, P. A., and Quintiliani, R., 1975, Defective regulation of chemotaxis in cirrhosis, J. Lab. Clin. Med. 85:621.PubMedGoogle Scholar
  156. Maderazo, E. G., Ward, P. A., Woronick, C. L., Kubik, J., and DeGraff, A. C., 1976, Leukotactic dysfunction in sarcoidosis, Ann. Intern. Med. 84:414.PubMedGoogle Scholar
  157. Mandell, G. L., 1972, Staphylococcal infection and leukocyte bactericidal defect in a 22 year old woman, Ann. Intern. Med. 130:754.Google Scholar
  158. Mass, M. F., Dean, P. B., Weston, W. L., and Humbert, J. R., 1975, Leukocyte migration in vivo: A new method of study, J. Lab. Clin. Med. 86:1040.PubMedGoogle Scholar
  159. Matoth, Y., 1952, Phagocytic and ameboid activities of the leukocytes in the newborn infant, Pediatrics 9: 748.PubMedGoogle Scholar
  160. Mawhinney, H., Killen, M., Fleming, W. A., and Roy, A. D., 1980, The hyperimmunoglobulin E syndrome—a neutrophil chemotactic defect reversible by histamine H2 receptor blockage? Clin. Immunol. Immunopathol. 17:483.PubMedGoogle Scholar
  161. McCall, C. E., Caves, J., Cooper, R., and DeChatelet, L., 1971, Functional characteristics of human toxic neutrophils. J. Infect. Dis. 135:376.Google Scholar
  162. McCall, C. E., DeChatelet, L. R., Brown, D., and Lachmann, P., 1974, New biologic activity following intravascular activation of the complement cascade, Nature 249:841.PubMedGoogle Scholar
  163. McGeady, S. J., and Buckley, R. N., 1975, Depression of cell-mediated immunity in atopic eczema, J. Allergy Clin. Immunol. 56:393.PubMedGoogle Scholar
  164. McPhail, L., DeChatelet, L. R., Shirley, P. S., Wilfert, C., Johnston, R. B., and McCall, C. E., 1977, Deficiency of NADPH oxidase in activity in chronic granulomatous disease, Pediatrics 90:213.Google Scholar
  165. Metchnikoff, E., 1905, Immunity in Infective Diseases (F. G. Binnie, transl.), Cambridge University Press, London.Google Scholar
  166. Miles, A. A., 1964, The acute reactions of injury as an antimicrobial defense, in: International Symposium on Injury, Inflammation and Immunity (L. Thomas and J. W. Uhr, eds.), 1st ed., pp. 162–182, Williams & Wilkins, Baltimore.Google Scholar
  167. Miles, A. A., Miles, E. M., and Burke, J., 1957, The value and duration of defense reactions of the skin to primary lodgement of bacteria, Br. J. Exp. Pathol. 38:79.PubMedGoogle Scholar
  168. Miller, M. E., 1971, Chemotactic function in the human neonate: Humoral and cellular aspects, Pediatr. Res. 5:487.Google Scholar
  169. Miller, M. E., 1973, Leukocyte movement-in vitro and in vivo correlates, J. Pediatr. 83: 1104.PubMedGoogle Scholar
  170. Miller, M. E., 1975, Developmental maturation of human neutrophil motility and its relationship to membrane deformity, in: The Phagocytic Cell in Host Resistance (J. A. Bellanti and D. H. Dayton, eds.), pp. 295–302, Raven Press, New York.Google Scholar
  171. Miller, M. E., and Baker, L., 1972, Leukocyte functions in juvenile diabetes mellitus: Humoral and cellular aspects, J. Pediatr. 81:979.PubMedGoogle Scholar
  172. Miller, M. E., Oski, F. A., and Harris, M. B., 1971, Lazy-leukocyte syndrome, Lancet 1: 1665.Google Scholar
  173. Miller, M. E., Norman, M. E., Koblenger, P. J., and Schonauer, T., 1973, A new familial defect of neutrophil movement, J. Lab. Clin. Med. 82:1.PubMedGoogle Scholar
  174. Mills, E. L., and Quie, P. G., 1980, Congenital disorders of the functions of polymorphonuclear neutrophils, Rev. Infect. Dis. 2:505.PubMedGoogle Scholar
  175. Mills, E. L., Thompson, T., Björkstein, B., Filipovich, D., and Quie, P. G., 1979, The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers, Pediatrics 63:429.PubMedGoogle Scholar
  176. Mills, E. L., Rholl, K. S., and Quie, P. G., 1980a, Luminol-amplified chemiluminescence: A sensitive method for detecting the carrier state in chronic granulomatous disease, J. Clin. Microbiol. 12:52.PubMedGoogle Scholar
  177. Mills, E. L., Rholl, K. S., and Quie, P. G., 1980b, X-linked inheritance in females with chronic granulomatous disease, J. Clin. Invest. 66:332.PubMedGoogle Scholar
  178. Moellering, R. C., Jr., and Weinberg, A. N., 1970, Persistent Salmonella infection in a female carrier of chronic granulomatous disease, Ann. Intern. Med. 73:595.PubMedGoogle Scholar
  179. Mowat, A. G., and Baum, J., 1971a, Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis, J. Clin. Invest. 50:2541.PubMedGoogle Scholar
  180. Mowat, A. G., and Baum, J., 1971b, Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus, N. Engl. J. Med. 284:621.PubMedGoogle Scholar
  181. Mowat, A. G., and Baum, J., 1971c, Polymorphonuclear leukocyte chemotaxis in patients with bacterial infection, Br. Med. J. 3:617.PubMedGoogle Scholar
  182. Nath, J., Flain, M., and Gallin, J. I., 1980, Tubulin tyrosylation in normal and ChediakHigashi syndrome neutrophils, J. Cell Biol. 87:1952.Google Scholar
  183. Nelson, R. D., Quie, P. G., and Simmons, R. L., 1975, Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes, J. Immunol. 115:1650.PubMedGoogle Scholar
  184. Newburger, P. E., Cohen, H. J., Rothchild, S. B., Hobbins, J. C., Malawista, S. E., and Mahoney, M. J., 1979, Prenatal diagnosis of chronic granulomatous disease, N. Engl. J. Med. 300: 178.PubMedGoogle Scholar
  185. Norman, M. E., and Miller, M. E., 1973, Spontaneous chemotaxis in patients with glomerulonephritis and the nephrotic syndrome, J. Pediatr. 83:390.PubMedGoogle Scholar
  186. Norman, M. E., and Miller, M. E., 1974, Spontaneous chemotaxis in acute glomerulonephritis: Demonstration of a positive correlation with disease activity, J. Pediatr. 85:20.PubMedGoogle Scholar
  187. O’Flaherty, J. T., Kreutzer, D. L., and Ward, P. A., 1977, Neutrophil aggregation and swelling induced by chemotactic agents, J. Immunol. 119:232.PubMedGoogle Scholar
  188. Ogden, B. E., Krueger, G. G., and Hill, H. R., 1979, Lymphocyte suppressor activity in atopic eczema, Clin. Exp. Immunol. 35:269.PubMedGoogle Scholar
  189. Oliver, J. M., and Zurier, R. B., 1976, Correction of characteristic abnormalities of microtube function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists-studies in vitro in man and in vivo in the beige mouse, J. Clin. Invest. 57:1239.PubMedGoogle Scholar
  190. Oliver, J. M., Zurier, R. B., and Berlin, R. D., 1975, Concanavalin A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice, Nature 253:471.PubMedGoogle Scholar
  191. Orr, W., and Ward, P. A., 1978, Quantitation of leukotaxis in agarose by three different methods, J. Immunol. Methods 20:95.PubMedGoogle Scholar
  192. Pahwa, S. G., Pahwa, R., Grimes, E., and Smithwick, E., 1977, Cellular and humoral components of monocyte and neutrophil chemotaxis in cord blood, Pediatr. Res. 11:677.PubMedGoogle Scholar
  193. Pahwa, S., Smithwick, E. M., Grimes, E. R., O’Reilly, R., Pahwa, R. N., and Good, R. A., 1978, Chemotactic defects in severe combined immunodeficiency, Pediatrics 92:43.Google Scholar
  194. Peerless, A. G., and Stiehm, E. R., 1983, Defective red blood cells and T-lymphocyte chemiluminescence in chronic granulomatous disease: Possible global membrane defect, Clin. Res. 31:A119.Google Scholar
  195. Philippart, A. I., Colodny, A. H., and Baehner, R. L., 1972, Continuous antibiotic therapy in chronic granulomatous disease: Preliminary communication, Pediatrics 50:923.PubMedGoogle Scholar
  196. Pike, M. C., and Snyderman, R., 1976, Augmentation of human monocyte chemotactic response by levamisole, Nature 201:136.Google Scholar
  197. Pross, S. H., Hallock, J. A., Armstrong, R., and Fishel, C. W., 1977, Complement and Fc receptors on cord blood and adult neutrophils, Pediatr. Res. 11:135.PubMedGoogle Scholar
  198. Quie, P. G., White, J. G., Holmes, B., and Good, R. A., 1967, In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood, J. Clin. Invest. 46:668.PubMedGoogle Scholar
  199. Raubitschek, A. A., Levin, A. S., Stites, D. P., Shaw, E. B., and Freidenberg, H. H., 1973, Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease, Pediatrics 51:230.PubMedGoogle Scholar
  200. Rebora, A., Dallegri, F., and Patrone, F., 1980, Neutrophil dysfunction and repeated infections: Influence of levamisole and ascorbic acid, Br. J. Dermatol. 102:49.PubMedGoogle Scholar
  201. Rebuck, J. W., and Crowley, J. H., 1955, A method of studying leukocytic functions in vivo, Ann. NY Acad. Sci. 59:757.PubMedGoogle Scholar
  202. Repine, J. E., Rasmussen, B. R., and White, J. G., 1979, An improved nitroblue tetrazolium (NBT) test using phorbol myristate acetate (PMA) coated coverslips, Am. J. Clin. Pathol. 71:582.PubMedGoogle Scholar
  203. Rich, K. C., Neuman, C. G., and Stiehm, E. R., 1977, Neutrophil chemotaxis in malnourished Ghandian children, in: Malnutrition and the Immune Response (Suskind, R. M., ed.), pp. 271–275, Raven Press, New York.Google Scholar
  204. Rivkin, I., and Becker, E. L., 1972, Possible implication of cyclic 3′5′-adenosine monophosphate in the chemotaxis of rabbit peritoneal polymorphonuclear leukocytes, Fed. Proc. 31:657.Google Scholar
  205. Rodey, G. E., Park, B. H., Ford, D. K., Gray, B. H., and Good, R. H., 1970, Defective bactericidal activity of peripheral blood leukocytes in lipochrome histiocytosis, Am. J. Med. 49:322.PubMedGoogle Scholar
  206. Roos, D., Weening, R. S., Voetman, A. A., van Schaik, M. L. J., Bot, A. A. M., Meerhof, L. J., and Loos, J. A., 1979, Protection of phagocytic leukocytes by endogenous glutathione: Studies in a family with glutathione reductase deficiency, Blood 53:851.PubMedGoogle Scholar
  207. Rosen, E. U., Geefhuysen, J., Anderson, R., Joffe, M., and Rabson, A. R., 1975, Leucocyte function in children with kwashiorkor, Arch. Dis. Child. 50:220.PubMedGoogle Scholar
  208. Rosen, H., and Klebanoff, S. J., 1976, Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes, J. Clin. Invest. 58:50.PubMedGoogle Scholar
  209. Rosenfeld, S. I., Baum, J., Steigbigel, R. T., and Leddy, J. P., 1976, Hereditary deficiency of the fifth component of complement in man, J. Clin. Invest. 57:1635.PubMedGoogle Scholar
  210. Rosenthal, M., Trabert, U., and Müeller, W., 1976, Leucocytotoxic effect of levamisole, Lancet 1:369.PubMedGoogle Scholar
  211. Rosner, R., Kozinn, P. J., and Jervis, G. A., 1973, Leukocyte function and serum immunoglobulins in Down’s syndrome, NY State J. Med. 73:672.Google Scholar
  212. Rubin, J. L., Griffiths, R. W., and Hill, H. R., 1978, Allergen induced depression of neutrophil chemotaxis in allergic individuals, J. Allergy Clin. Immunol. 62:301.PubMedGoogle Scholar
  213. Rutenberg, W. D., Yang, M. C., Doberstyn, B., and Bellanti, J. A., 1977, Multiple leukocyte abnormalities in chronic granulomatous disease: A familial study, Pediatr. Res. 11:158.PubMedGoogle Scholar
  214. Saitoh, H., Komiyama, A., Norose, N., Morosawa, H., and Akabane T., 1981, Development of the accelerated phase during ascorbic acid therapy in Chediak-Hagashi syndrome and efficacy of colchicine on its management, Br. J. Haematol. 48:79.PubMedGoogle Scholar
  215. Schopfer, K., and Douglas, S. D., 1976, Neutrophil function in children with kwashiorkor, J. Lab. Clin. Med. 88:450.PubMedGoogle Scholar
  216. Schopfer, K., Baerlocher, K., Price, P., Krech, V., Quie, P. G., and Douglas, S. D., 1979, Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcal aureus infections, N. Engl. J. Med. 300:835.PubMedGoogle Scholar
  217. Segal, A. W., and Loewi, G., 1976, Neutrophil dysfunction in Crohn’s disease, Lancet 2:219.PubMedGoogle Scholar
  218. Segal, A. W., Webster, D., Jones, Q. T. G., and Allison, A. D., 1978, Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease, Lancet 2:446.PubMedGoogle Scholar
  219. Segal, A. W., Cross, A. R., Garcia, R. C., Borregaard, N., Valerius, N. H., Soothill, J. F., and Jones, D. T. G., 1983, Absence of cytochrome b-245 in chronic granulomatous disease: A multicenter European evaluation of its incidence and relevance, N. Engl. J. Med. 308: 245.PubMedGoogle Scholar
  220. Seger, R. A., Baumgartner, S., Tiefenauer, L. X., and Gmünder, F. K., 1981, Chronic granulomatous disease: Effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function, Helv. Paediatr. Acta 36:579.PubMedGoogle Scholar
  221. Shigeoka, A. O., and Hill, H. R., 1978, Recurrent pseudomonas infection associated with neutrophil dysfunction, Scand. J. Infect. Dis. 10:307.PubMedGoogle Scholar
  222. Shigeoka, A. O., Hall, R. T., and Hill, H. R., 1978, Blood-transfusion in group B streptococcal sepsis, Lancet 1:636.PubMedGoogle Scholar
  223. Shigeoka, A. O., Santos, J. I., and Hill, H. R., 1979, Functional analysis of neutrophil granulocytes from healthy, infected and stressed neonates, J. Pediatr. 95:454.PubMedGoogle Scholar
  224. Shigeoka, A. O., Charette, R. P., Wyman, M. L., and Hill, H. R., 1981, Defective oxidative metabolic responses of neutrophils from stressed neonates, J. Pediatr. 98:392.PubMedGoogle Scholar
  225. Shurin, S. B., Socransky, S. S., Sweeney, E., and Stossel, T. P., 1979, A neutrophil disorder induced by Capnocytophaga, a dental micro-organism, N. Engl. J. Med. 301:849.PubMedGoogle Scholar
  226. Smith, C. W., Hollers, J. C., Dupree, E., Goldman, A. S., and Lord, R. A., 1972, A serum inhibitor of leukotaxis in a child with recurrent infections, J. Lab. Clin. Med. 79:878.PubMedGoogle Scholar
  227. Snyderman, R., and Pike, M. C., 1978, Pathophysiologic aspects of leukocyte chemotaxis: Identification of a specific chemotactic factor binding site on human granulocytes and defects of macrophage function associated with neoplasia, in: Leukocyte Chemotaxis: Methods, Physiology, and Clinical Implications (J. I. Gallin and P. G. Quie, eds.), pp. 357–378, Raven Press, New York.Google Scholar
  228. Snyderman, R., Altman, L. C., Frankel, A., and Blaese, R. M., 1973, Defective mononuclear leukocyte chemotaxis: A previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis, Ann. Intern. Med. 78:509.PubMedGoogle Scholar
  229. Soderberg-Warner, M., Rice-Mendoza, C. A., Mendoza, G. R., and Stiehm, E. R., 1983, Neutrophil and T lymphocyte characteristics of two patients with hyper-IgE syndrome, Pediatr. Res. 17:820.PubMedGoogle Scholar
  230. Soriano, R. B., South, M. A., Goldman, A. S., and Smith, C. W., 1973, Defect of neutrophil motility in a child with recurrent bacterial infections and disseminated cytomegalovirus infection, J. Pediatr. 83:951.PubMedGoogle Scholar
  231. Spielberg, S. P., Boxer, L. A., Oliver, J. M., Allen, J. M., and Schulman, J. D., 1979, Oxidative damage to neutrophils in glutathione synthetase deficiency, Br. J. Haematol. 42:215.PubMedGoogle Scholar
  232. Steerman, R. L., Snyderman, R., Leikin, S. L., and Colten, H. R., 1971, Intrinsic defect of the polymophonuclear leukocyte resulting in impaired chemotaxis and phagocytosis, Clin. Exp. Immunol. 9:939.PubMedGoogle Scholar
  233. Stevens, P., Winston, D. J., and Van Dyke, K., 1978, In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: Utility in patients with severe neutrogenia and cellular deficiency states, Infect. Immun. 22:41.PubMedGoogle Scholar
  234. Stossel, T. P., 1973, Evaluation of opsonic and leukocyte function with a spectrophotometric test in patients with infection and with phagocytic disorders, Blood 42:121.PubMedGoogle Scholar
  235. Stossel, T. P., 1974, Phagocytosis, N. Engl. J. Med. 290:717, 774, 833.Google Scholar
  236. Strauss, R. G., Bove, K. E., Jones, J. F., Mauer, A. M., and Fulginiti, V. A., 1974, An anomaly of neutrophil morphology with impaired function, N. Engl. J. Med. 290:478.PubMedGoogle Scholar
  237. Strauss, R. G., Connett, J. E., Gale, R. P., Bloomfield, C. D., Herzig, G. P., McCullough, J., Maguire, L. C., Winston, D. J., Ho, W., Stump, D. C., Miller, W. V., and Koepke, J. A., 1981, A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia, N. Engl. J. Med. 305:598.Google Scholar
  238. Van der Meer, J. W. M., Van Zwet, T. L., and Van Forth, R., 1975, New familial defect in microbicidal function of polymorphonuclear leukocytes, Lancet 2:630.PubMedGoogle Scholar
  239. Van Dyke, T. E., Reilly, A. A., Horoszewicz, H., Gargliardi, N., and Genco, R. J., 1979, A rapid semiautomated procedure for the evaluation of leukocyte locomotion in the micropore filter assay, J. Immunol. Methods 31:271.PubMedGoogle Scholar
  240. Van Epps, D. E., and Williams, R. C., Jr., 1978, Serum inhibitors of leukocyte chemotaxis and their relationship to skin test anergy, in: Leukocyte Chemotaxis: Methods, Physiology and Clinical Implications (J. I. Gallin and P. G. Quie, eds.), pp. 237–253, Raven Press, New York.Google Scholar
  241. Van Epps, D, Palmer, D. L., and Williams, R. C., 1974, Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy, J. Immunol. 113:189.PubMedGoogle Scholar
  242. Van Scoy, R. E., Hill, H. R., Ritts, R. E., Jr., and Quie, P. G., 1975, Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis and hyperimmunoglobulinemia E, Ann. Intern. Med. 82:766.PubMedGoogle Scholar
  243. Ward, P. A., and Berenberg, J. L., 1974, Defective regulation of inflammatory mediators in Hodgkin’s disease, N. Engl. J. Med. 290:76.PubMedGoogle Scholar
  244. Ward, P. A., and Ozols, J., 1976, Characterization of the protease activity of the chemotactic factor inactivator, J. Clin. Invest. 58:123.PubMedGoogle Scholar
  245. Ward, P. A., and Schlegel, R. J., 1969, Impaired leukotactic responsiveness in a child with recurrent infection, Lancet 2:344.PubMedGoogle Scholar
  246. Ward, P. A., Cochrane, C. G., and Müller-Eberhard, H. J., 1965, The role of serum complement in chemotaxis of leukocytes in vitro, J. Exp. Med. 122:327.Google Scholar
  247. Ward, P. A., Goralnick, S., and Bullock, W. E., 1976, Defective leukotaxis in patients with lepromatous leprosy, J. Lab. Clin. Med. 87:1025.PubMedGoogle Scholar
  248. Warden, G. D., and Maxwell, J. G., 1976, Leukocyte chemotaxis in vitro in chronic dialysis patients and after renal transplantation, Surg. Forum 27:323.PubMedGoogle Scholar
  249. Warden, G. D., Mason, A. D., Jr., and Pruitt, B. A., Jr., 1974, Evaluation of leukocyte chemotaxis in vitro in thermally injured patients, J. Clin. Invest. 54:1001.PubMedGoogle Scholar
  250. Weening, R. S., Schoorel, E. P., Roos, D., van Schaik, M. L. J., Voetman, A. A., Bot, A. A. M., Batenburg- Plenter, A. M., Willems, Ch., Zeijlemaker, W. P., and Astaldi, A., 1981, Effect of ascorbate on abnormal neutrophil, platelet and lymphocyte function in a patient with the Chediak-Higashi syndrome, Blood 57:856.PubMedGoogle Scholar
  251. Weiblen, B. J., Forstrom, L., and McCullough, J., 1979, Studies of the kinetics of indium111-labeled granulocytes, J. Lab. Clin. Med. 94:246.PubMedGoogle Scholar
  252. Weston, W. L., Humbert, J. R., August, C. S., Harnett, Mass, M. F., Dean, P. B., and Hagen, I. M., 1977, A hyperimmunoglobulin E syndrome with normal chemotaxis in vitro and defective leukotaxis in vivo, J. Allergy Clin. Immunol. 59:115.PubMedGoogle Scholar
  253. White, J. G., and Clawson, C. C., 1979, The Chediak-Higaski syndrome: Microtubules in monocytes and lymphocytes, Am. J. Hematol. 7:349.PubMedGoogle Scholar
  254. Witemeyer, S., and Van Epps, D. E., 1976, A familial defect in cellular chemotaxis associated with redheadedness and recurrent infection, J. Pediatr. 89:33.PubMedGoogle Scholar
  255. Wright, D. G., Kirkpatrick, C. H., and Gallin, J. I., 1977, Effect of levamisole on normal and abnormal leukocyte locomotion, J. Clin. Invest. 59:941.PubMedGoogle Scholar
  256. Wright, W. C., Jr., Ank, B. J., Herbert, J., and Stiehm, E. R., 1975, Decreased bactericidal activity of leukocytes of stressed newborn infants, Pediatrics 56:579.PubMedGoogle Scholar
  257. Zimmerman, G. A., Renzetti, A. D., and Hill, H. R., 1983, Functional and metabolic activity of circulating polymorphonuclear leukocytes from patients with the adult respiratory distress syndrome, Am. Rev. Respir. Dis. 127:290.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Harry R. Hill
    • 1
  1. 1.Departments of Pathology and PediatricsUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations